`
`Merck Exhibit 2210, Page 1
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`
`
`
`J. M. ADAMS AND R. W. H. SMALL 833 tions of the atoms converted to those for P-42~c and averaged. An absorption correction was computed with ABSCOR in the X-RAY 63 system on the Chilton ATLAS. Refinement was carried out with FMLS of Bracher (1967). The 19 reflexions for which the intensity was less than one e.s.d, of the background were left out of the refinement and calculation of R. Ten reflexions considered to be suffering from extinction were also left out of the refinement. The H atoms of the guani- dinium ions were found from a difference synthesis although it did not prove possible to locate the H atom of the HPO]- group or those of the water molecule. The H atoms were refined isotropically throughout. In an attempt to correct for extinction in a systematic way the method of Larson (1970) was used. The output from a structure factor calculation was used to obtain an isotropic extinction parameter which was then used to correct the [Fol values. One cycle of FMLS was per- formed and the procedure repeated. Unit weights were used, and on the last cycle the parameter shifts were of the order of the appropriate standard deviations. The final R was 0.066. Scattering factors were taken from International Tables for X-ray Crystallography (1962). Final atomic and thermal parameters are given in Tables 2, 3 and 4.* Table 4. Isotropic temperature factors for the hydrogen atoms (A 2) H(1) 5.6 (2.6) H(5) 3.8 (2.3) H(9) 4.6 (2.6) H(2) 7-1 (3.1) H(6) 1.0 (1-5) H(10) 2-4 (1"8) H(3) 2"4(1"8) H(7) 7-3(3-7) H(ll) 4"7(2"6) H(4) 3"4(2"1) H(8) 1"0(1"4) H(12) 3-1 (2"1) Table 2. Fractional atomic coordinates and their standard deviations x y z P 0.87102 (7) 0.23599 (7) 0.20606 (19) O(1) 0.9352 (2) 0.1726 (2) 0.1961 (7) O(2) 0.9032 (2) 0.3189 (2) 0.1908 (7) 0(3) 0.8163 (3) 0.2191 (3) 0.0282 (5) 0(4) 0.8192 (2) 0'2222 (3) 0.3747 (5) 0(5) 0.9611 (3) 0.3603 (3) 0.8504 (7) C(1) 0.6073 (3) 0.1479 (3) 0.2837 (9) N(1) 0.5505 (3) 0.1032 (3) 0.2150 (9) N(2) 0.5926 (3) 0.2228 (3) 0.3334 (8) N(3) 0.6808 (3) 0.1198 (3) 0.2960 (9) C(2) 0.9826 (3) 0.1559 (3) 0.6967 (9) N(4) 0.9071 (3) 0.1789 (3) 0.6974 (8) N(5) 1.0187 (3) 0.1384 (4) 0.8524 (7) N(6) 1.0209 (3) 0.1477 (4) 0.5389 (7) H(1) 0-562 (6) 0.057 (7) 0.119 (14) H(2) 0.505 (7) 0.120 (6) 0.214 (17) H(3) 0.555 (5) 0.234 (5) 0.349 (12) H(4) 0.640 (5) 0.261 (5) 0.330 (13) H(5) 0.733 (5) 0.163 (5) 0.266 (14) H(6) 0.780 (4) 0.060 (4) 0.258 (10) H(7) 0.887 (8) 0.204 (7) 0.541 (18) H(8) 0-880 (4) 0-188 (4) 0-799 (11) H(9) 0"985 (6) 0.126 (6) 0-1003 (14) H(10) 1"061 (5) 0"100 (5) 0-802 (13) H(ll) 1-093 (6) 0"128 (6) 0.618 (15) H(12) 1.011 (6) 0.157 (5) 0-432 (12) Description and discussion of the structure Bond lengths and angles are in Table 5, least-squares planes in Table 6 and details of the hydrogen bonding in Table 7. The guanidinium ions are planar within experimental error; the large standard deviations of the H atoms preclude any detailed discussion of them. The C-N lengths are similar to those found in other guanidinium or substituted guanidinium salts [see e.g. Adams & Small (1974), Cotton, Day, Hazen & Larsen (1973), Cotton, Day, Hazen, Larsen & Wong (1974)]. The monohydrogen phosphate ions show one relatively long P-O distance for the P-O-H bond and three shorter distances for the remaining P-O bonds. This contrasts with the case of bis(methylguanidinium) hy- drogen phosphate (Cotton et al., 1974) where there are two long and two short P-O bonds, a fact attributed to extensive hydrogen-bonding interactions influencing the electronic distribution of the phosphate. * A list of structure factors has been deposited with the British Library Lending Division as Supplementary Publica- tion No. SUP 31272 (6 pp.). Copies may be obtained through The Executive Secretary, International Union of Crystallog- raphy, 13 White Friars, Chester CH 1 1 NZ, England. Table 3. Temperature factors, with standard deviations for the 'heavy' atoms P O(1) 0(2) 0(3) 0(4) 0(5) C(1) N(1) N(2) N(3) C(2) Y(4) Y(5) N(6 ~ T= exp [- 1 0- 5(h2bl i + k2b22 +/2ba3 + hkba 2 + hlb13 + klb23)] • bxt b22 ba3 b12 b13 b23 85 (4) 102 (4) 514 (19) -6 (6) 56 (19) -57 (18) 155 (12) 221 (14) 773 (67) 156 (21) 50 (60) -97 (65) 225 (14) 152 (12) 1084 (79) -166 (22) 59 (68) -88 (63) 184 (14) 161 (14) 578 (66) 25 (25) -95 (54) -71 (53) 143 (14) 218 (15) 693 (67) -20 (26) 239 (54) -61 (58) 180 (15) 333 (19) 1654 (101) -37 (28) 31 (67) 461 (78) 170 (17) 158 (16) 915 (97) 1 (27) 254 (83) 59 (82) 148 (15) 233 (18) 1898 (118) -44 (26) 146 (86) -328 (95) 162 (16) 219 (17) 1610 (117) 95 (27) -67 (75) -469 (81) 159 (15) 212 (17) 1810 (115) 54 (27) 99 (90) 60 (96) 162 (18) 165 (17) 868 (93) 13 (27) 24 (82) -236 (85) 166 (15) 295 (18) 970 (86) 62 (28) -95 (79) -263 (91) 211 (19) 358 (23) 799 (88) 132 (35) -144 (67) -169 (80) 247 (21) 424 (27) 864 (96) 142 (38) 227 (78) 32 (90)
`
`Merck Exhibit 2210, Page 2
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`
`
`
`834 BISGUANIDINIUM HYDROGEN PHOSPHATE MONOHYDRATE The structure [Fig. l(a)-(c)] consists of a three- dimensional hydrogen-bonding network in which 13 of the 15 H atoms are used. The phosphate groups related by the c glide are joined by hydrogen bonds from the water oxygen, 0(5). There are also relatively short hydrogen bonds, O(3)-H... O(4), between them o¢_1~, ~0(5) ~4) • °'''Oo °° ...~" 0(3) [°•° .,°1 : ,~/~i ' ,o(s~ 4) I .." ~o.O" ••'1 ,o • ••° •|.•° : I "" ".N41 °'o, I "',[, | °•°, ' Z i I t 3) I °•° I (a) ~0(I) ---,0(I) o((cid:127)O 4) (I) *',o ••o •, ,0(5)". "..N(=) o,. ,o - ~41 ,." °( o0~'~'°(11 ~ N.(.S) ........ ~ N(6) o.(5) • ?(3) .......... ;, o(s) F' . """ rC(2) /.~r~ ....... 0(5) cxIJ // I 7/ . ...... "., ~,,j~/ gN(,.). /" I "'% /•/ ~~. .... ,.. o~. ~, .//' T \ " ):..'." ".. I~-,-,~ ~ ./-'.... -.......(3~../. .... / ",. ..... 1:-" ~ •.-" (c) Fig. 1. (a) Projection onto (110) of the hydrogen-bonded phosphate chain• Hydrogen bonds involving water molecules and HPO~- ions are shown• (b) Projection on to (110) of the hydrogen bonding to the phosphate chains by the guanidinium ion C(2), N(4), N(5), N(6). (c) Projection of the structure on to (001) with hydrogen bonds involving the C(1), N(1), N(2), N(3) guanidinium group shown.
`
`Merck Exhibit 2210, Page 3
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`
`
`
`J. M. ADAMS AND R. W. H. SMALL 835 (ii) NI__ H ......... O.--P~ / --c' X~I -H ......... O---p~ NI-H ......... 0 ........ I /N-H......... (iii) -C . "OH2 .. XN-H'"'" 1 / ......... o---P~ .." 0v) xc__d a" / SH" .... ......... O~P~ Fig. 2. Schematic drawing of hydrogen-bonding geometry. (i) N(Z)-H(4). • .O(3), N(3)-H(5)..-0(4). (ii) N(4)-H(8). • • O(3), N(5)-H(9)...O(I). (iii) N(1)-H(1)...O(5), N(3)- H(6). • "0(5). (iv) N(4)-H(8)... O(3), N(4)-H(7)... 0(4). Table 5. Bond lengths and angles P - O(1) 1-521 (5)/~ O(1)--P 0(2) 113.1 (3) ° P .. 0(2) 1.502 (5) O(1)--P 0(3) 104.2 (3) P 0(3) 1.610 (5) O(1)--P 0(4) 109.8 (3) P--O(4) 1.520 (5) O(2)--P O(3) 108-2 (3) C(1)-N(1) 1.315 (8) O(2)--P 0(4) 114.1 (3) C(1)-N(2) 1.335 (8) O(3)--P 0(4) 106.8 (3) C(1)-N(3) 1.329 (8) N(1)--C(1)-N(2) 120.5 (5) C(2)-N(4) 1-330 (9) N(1)--C(1)-N(3) 120.0 (5) C(2)-N(5) 1.315 (9) N(E)--C(1)-N(3) 119.4 (5) C(2)-N(6) 1.320 (9) N(4)--C(2)-N(5) 120.2 (6) N(I)-H(1) 1.07 (11) N(4)--C(2)-N(6) 120.0 (6) N(1)-H(2) 0.82 (10) N(5)--C(2)-N(6) 119.7 (6) N(2)-H(3) 0.66 (11) H(1)--N(I)-H(2) 115 (9) N(Z)-H(4) 1.02 (8) C(1)--N(1)-H(1) 122 (6) N(3)-H(5) 1.16 (9) C(1)--N(1)-H(2) 119 (7) N(3)-H(6) 1.05(8) H(3)--N(2)-H(4) 124(10) N(4)-H(7) 1.26 (14) C(1)--N(Z)-H(3) 119 (9) N(4)-H(8) 0.88 (9) C(1)--N(Z)-H(4) 116 (4) N(5)-H(9) 1.25 (11) H(5)--N(3)-H(6) 124 (7) N(5)-H(10) 1.03 (14) C(1)--N(3)-H(5) 118 (5) N(6)-H(ll) 1.38 (10) C(1)--N(3)-H(6) 109 (5) N(6)-H(12) 0.86 (9) H(7)--N(4)-H(8) 123 (8) C(2)--N(4)-H(7) 111 (6) C(2)--N(4)-H(8) 124 (6) H(9)--N(5)-H(10) 121 (9) C(2)--N(5)-H(9) 125(5) C(2)--N(5)-H(10) 99 (8) H(ll)-N(6)-H(12) 139 (8) C(2)--N(6)-H(11) 95 (4) C(2)--N(6)-H(12) 125 (6) of length similar to those found in orthophosphoric acid (Furberg, 1955). The chain of glide-related phosphate ions is also linked up with other chains by hydrogen bonds involving bridging guanidinium ions. The water oxygen atom, O(5), accepts two hydrogen bonds, from N(1)-H(1) and N(3)-H(6). 0(3) also accepts two hy- drogen bonds, but O(1), 0(2) and 0(4) each accept three hydrogen bonds. H(3) and H(11) bonded to N(2) and N(6) respectively are not involved in hydrogen bonding. The variety of different hydrogen-bonding geometries is schematized in Fig. 2. Table 6. Deviations of atoms from the least-squares planes (]k) (a) Plane through C(1), N(1), N(2), N(3) - 0.2065x- 0.3214y + 0.9242z-- - 1.0276 C(1) 0.016 N(2) -0.005 N(1) -0.005 N(3) -0"005 (b) Plane through C(2), N(4), N(5), N(6) 0-3025x + 0.9506y + 0.0703z = 7-8441 C(2) 0"012 N(5) -0"004 N(4) - 0.004 N(6) - 0-004 Table 7. Hydrogen-bonding geometry (a) Distances (A) 0(3)- • 0(4') N(1). H(1). N(1). H(2). N(2)" H(4)- N(3). H(5). N(3). H(6). N(4)- 2-568 (7) • 0(5 ii) 2.866(7) • 0(5 H) 2.08 (11) • O(2 m) 2.888 (7) • O(2 "i) 2.11 (10) • 0(3 i) 3.003 (7) • 0(3 ~) 2.17 (8) • 0(4) 2.955 (7) • 0(4) 1-93 (10) • O(5") 2.958 (7) • O(5 n) 1-96 (8) • 0(4) 2.864 (8) (b) Angles N(1)-H(1)..-0(5 l~) 128 (8) N(1)-H(2)..-0(2 m) 158 (10) N(2)-H(4)... 0(3 ~) 137 (6) N(3)-H(5)-.. 0(4) 145 (9) N(3)-H(6)" • "O(5 n) 158 (7) Symmetry code (i) ½+y, ½+x, ½+z; (ii) )7, x, 2; (iii) ½+x, ½-y, ½-z; H(7)..O(4) 1.69 (13) N(4). .O(3 iV) 2.924 (8) H(8)- .0(3 i,) 2.05(9) N(5). .O(1 '*) 2.918 (8) H(9)" "O(1 ~V) 1"81(11) N(5)..O(1") 2.896 (8) H(10)..O(1 v) 1.97 (14) N(6)-..O(1) 2.904 (8) H(12)..O(1) 2.06 (9) 0(5)-..O(2 t*) 2.744 (8) 0(5).. -O(2 ~) 2.756 (7) N(4)-H(7) .... 0(4) 153 (10) N(4)-H(8) .... 0(3 iv) 176 (8) N(5)-H(9) .... O(1 iv) 144 (8) N(5)-H(10)...O(1 *) 148 (11) N(6)-H(12).--O(1) 170 (9) (iv) x, y, 1 + z (v) y, ~, We thank the Science Research Council for the pro- vision of a maintenance grant for one of us (JMA). References ADAMS, J. M. & PPaTC~_ARD, R. G. (1975). J. Appl. Cryst. 8, 382-395. ADAMS, J. M. & SMALL, R. W. H. (1974). Acta Cryst. B30, 2191-2193. BRAC~ER, B. H. (1967). UKAEA Research Report AERE- R5478. COTTON, F. A., DAY, V. W., HAZEN, E. E. JR ~¢ LARSEN, S. (1973). J. Amer. Chem. Soc. 95, 4834-4840. Co-n'ON, F. A., DAY, V. W., HAZEN, E. E. JR, LARSEN, S. & WONG, S. T. K. (1974). J. Amer. Chem. Soc. 96, 4471- 4478. FURBERG, S. (1955). Aeta Chem. Seand. 9, 1557-I566. GERMAIN, G., MAIN, P. & WOOLFSON, M. M. (1970). Aeta Cryst. B26, 274-285. International Tables for X-ray Crystallography (1962). Vol. III. Birmingham: Kynoch Press. LARSON, A. C. (1970). Crystallographic Computing, pp. 291-294. Copenhagen: Munksgaard. SMALL, R. W. H. & TRAVERS, S. (1961). J. Sei. Instrum. 38, 205-206.
`
`Merck Exhibit 2210, Page 4
`Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
`IPR2020-00040
`
`